Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro
단일 도메인 상어 VNAR 항체는 시험관 내에서 SARS-CoV-2 감염을 중화합니다
Article
Published on
Journal: FASEB journal : official publication of the Federa [Category] MERS, SARS, 변종, 진단,
Journal: FASEB journal : official publication of the Federa [Category] MERS, SARS, 변종, 진단,
[키워드] ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
angiotensin
angiotensin-converting enzyme 2
antibodies
antibody
Antigen
antigen receptor
approach
binding
blocking activity
Cell
clone
coronavirus
COVID-19
COVID-19 disease
disease
domain
E484K
epitope
exhibited
expressing
flexibility
high affinity
in vitro
infectivity assays
inhibitory
monoclonal antibodies
monoclonal antibody
mutant
N501Y
neutralize
Neutralizing
neutralizing antibody
offer
pandemic
receptor
Receptor binding domain
respiratory
retained
SARS-CoV-2
SARS-COV-2 infection
selected
severe acute respiratory syndrome Coronavirus
single domain antibody.
specificity
Spike protein
Spike protein receptor binding domain
tested
the spike protein
treat
treating COVID-19
unique
variant
Viral
virus
VNAR
was used
Wuhan
[DOI] 10.1096/fj.202100986RR PMC 바로가기 [Article Type] Article
[DOI] 10.1096/fj.202100986RR PMC 바로가기 [Article Type] Article